HTGF backs MicroDimensions

A group of business angels also backed the round.

The company will use the funding to expand its product portfolio. It claims the digital pathology market, which it operates in, will reach a market volume of $5.2bn by 2020.

HTGF and Bayern Kapital are regularly investing in startups together. In May, for instance, the two investors backed a €1.75m seed round for German composites production developer Cevotec.

Previous funding
In March 2014, MicroDimensions received seed funding from HTGF and Bayern Kapital.

Company
Founded in 2011 and based in Munich, MicroDimensions develops software for microscopic image processing and analysis. Its products allow 3D histology reconstruction, whole-slide image alignment, stereology and digital pathology viewing for pharmaceutical and biotech companies. Its products are notably used for drug testing.

People
High-Tech Gründerfonds – Marianne Mertens (investment manager).
MicroDimensions – Martin Groher (CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• DACH
• Technology
• Germany
• High-Tech Gründerfonds
• Venture